 This protocol is designed to use stereotactic body radiation therapy SBRT to deliver a boost dose to residual primary tumor after definitive doses of standard external beam radiation have been delivered concurrently with chemotherapy. It is designed to determine the toxicity profileside effects in the context of dose escalation of stereotactic body radiation therapy SBRT after definitive therapy with concurrent chemoradiation and to define the maximum tolerated dose. 